← Evidence map

ReviewFrontiers in pharmacology2026

Gut microbiota and the gut-liver axis in MASLD: mechanisms, immune regulation and therapeutic opportunities.

Jingjing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42662117